1. |
|
|
2. |
|
|
3. |
- Toriola, Adetunji T., et al.
(författare)
-
Free beta- human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer
- 2014
-
Ingår i: Future Oncology. - 1479-6694 .- 1744-8301. ; 10:3, s. 377-384
-
Tidskriftsartikel (refereegranskat)abstract
- Background: We investigated whether the free -human chorionic gonadotropin (free -hCG) would provide additional information to that provided by total hCG alone and thus be useful in future epidemiological studies relating hCG to maternal breast cancer risk. Materials & methods: Cases (n = 159) and controls (n = 286) were a subset of our previous study within the Northern Sweden Maternity Cohort on total hCG during primiparous pregnancy and breast cancer risk. Results: The associations between total hCG (hazard ratio: 0.79; 95% CI: 0.49-1.27), free -hCG (hazard ratio: 0.85; 95% CI: 0.33-2.18) and maternal risk of breast cancer were very similar in all analyses and mutual adjustment for either one had minor effects on the risk estimates. Conclusion: In the absence of a reliable assay on intact hCG, total hCG alone can be used in epidemiological studies investigating hCG and breast cancer risk, as free -hCG does not appear to provide any additional information.
|
|